Ma Ke, Zhang Yajuan, Hao Jian, Zhao Jing, Qi Ying, Liu Cong
Ke Ma, Clinical Laboratory, The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei, China.
Yajuan Zhang, Clinical Laboratory, The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei, China.
Pak J Med Sci. 2023 Mar-Apr;39(2):497-501. doi: 10.12669/pjms.39.2.6651.
To investigate the correlation between systemic immune inflammatory (SII) index, serum interleukin-35 (IL-35) and high mobility Group-Box one (HMGB-1) with the severity and prognosis of sepsis.
A retrospective analysis was performed on the clinical data of 209 patients with sepsis admitted to Ganzhou City People's Hospital from October 2019 to October 2021. One hundred eighteen patients in Group-A had common sepsis, and 91 patients in Group-B had septic shock, which were subdivided into the survival Group-And the mortality Group-According to the 28d prognosis. The levels of SII, IL-35 and HMGB-1 in different groups were compared, and their correlation with the severity and prognosis of sepsis was analyzed.
The levels of SII, IL-35 and HMGB-1 in Group-A were significantly lower than those in Group-B (p<0.05). The levels of SII, IL-35 and HMGB-1 in the survival group were significantly lower than those in the death group (p<0.05). Spearman correlation analysis showed that the levels of SII, IL-35, and HMGB-1 were significantly positively correlated with the severity of sepsis (p<0.05), and significantly positively correlated with the prognosis of patients with sepsis (p<0.05).
SII, IL-35 and HMGB-1 are remarkably correlated with the severity and prognosis of patients with sepsis. With the increasing in SII, IL-35 and HMGB-1 levels, patients will suffer from severe disease progression and poor prognosis, which require more clinical attention.
探讨全身免疫炎症(SII)指数、血清白细胞介素-35(IL-35)和高迁移率族蛋白B1(HMGB-1)与脓毒症严重程度及预后的相关性。
回顾性分析2019年10月至2021年10月在赣州市人民医院收治的209例脓毒症患者的临床资料。A组118例为普通脓毒症患者,B组91例为脓毒性休克患者,根据28天预后情况分为生存组和死亡组。比较不同组SII、IL-35和HMGB-1水平,并分析其与脓毒症严重程度及预后的相关性。
A组SII、IL-35和HMGB-1水平显著低于B组(p<0.05)。生存组SII、IL-35和HMGB-1水平显著低于死亡组(p<0.05)。Spearman相关性分析显示,SII、IL-35和HMGB-1水平与脓毒症严重程度显著正相关(p<0.05),与脓毒症患者预后显著正相关(p<0.05)。
SII、IL-35和HMGB-1与脓毒症患者的严重程度及预后显著相关。随着SII、IL-35和HMGB-1水平升高,患者病情进展严重,预后较差,需临床更多关注。